Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation [Phase 3]
Phase 3 trial update for vorasidenib (S095032/AG-881) in Asian participants with residual or recurrent Grade 2 IDH-mutant glioma; study stat…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment [Phase 2]
A Phase 2 clinical trial is testing Erdafitinib for recurrent glioma (including WHO grades 2–4) that has progressed after prior treatment; r…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET) [NA]
This clinical trial update notes the completion of a prospective study evaluating the contribution of 18F-FDOPA PET imaging to oncologic cer…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Chronic Convection Enhanced Delivery of Topotecan [Phase 1]
Phase 1 trial of chronic convection-enhanced delivery of topotecan for glioma has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations [Phase 1]
Phase 1 study of LY3410738 in patients with IDH1/IDH2-mutant advanced solid tumors, including cholangiocarcinoma, chondrosarcoma, and glioma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Sophrology Treatment for Patients With Glial Tumours Requiring Speech Therapy [NA]
A terminated clinical trial evaluating sophrology for patients with gliomas requiring speech therapy has posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab [Phase 2]
Phase II trial evaluating pulsed reduced-dose-rate radiation therapy with bevacizumab for glioma. The study was terminated and results have …
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption [NA]
This completed study evaluated the safety and feasibility of ExAblate–mediated blood-brain barrier disruption in glioma and glioblastoma.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases [EARLY_Phase 1]
This EARLY_PHASE1 trial evaluating ketoconazole before surgery in patients with recurrent glioma or breast cancer brain metastases was termi…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas [Phase 1]
Phase 1 trial assessing the safety of combining fluvastatin with celecoxib in glioma (optico-chiasmatic) has completed, focusing on safety a…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas [NA]
A completed trial evaluating temporally-modulated pulsed radiation therapy after prior EBRT in adults with recurrent IDH-mutant gliomas, inc…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Quality of Life and Neurocognitive Functioning [NA]
Completed clinical trial update examining quality of life and neurocognitive functioning in glioma patients.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma [EARLY_Phase 1]
Clinical trial update announcing an EARLY Phase 1 study of niraparib for newly diagnosed glioblastoma and recurrent glioma; the trial status…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients [EARLY_Phase 1]
Early-phase trial update reports completion of a Phase 1 study evaluating LY3214996 in combination with abemaciclib for recurrent glioblasto…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG [Phase 1]
Phase 1 safety study evaluating SBK2-ICG for fluorescence-guided imaging of malignant brain tumors, including glioma. The trial is currently…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. [Phase 2, Phase 3]
The DETERMINE trial's Arm 07 is studying dabrafenib plus trametinib in patients with BRAF V600 mutation-positive cancers across age groups; …
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors
This ClinicalTrials.gov update indicates the C-SMART trial, which assesses cognitive strategies, mindfulness, and rehabilitation therapy for…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Quality of Life and Cognitive Functioning in Patients With Glial Tumors [NA]
A clinical trial evaluating quality of life and cognitive functioning in patients with glial tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study of AG-120 and AG-881 in Subjects With Low Grade Glioma [Phase 1]
The study reports the completion of a Phase 1 trial evaluating AG-120 (ivosidenib) and AG-881 (vorasidenib) in subjects with low-grade gliom…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation [Phase 1]
Phase 1 study of AG-120 (ivosidenib) for IDH1-mutant advanced solid tumors, including glioma, has completed enrollment and data collection.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma [Phase 1]
This is a Phase 1 clinical trial evaluating memory-enriched T cells for recurrent or refractory Grade III-IV glioma, including glioblastoma …
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma [Phase 1]
Phase 1 trial evaluating tumor hypoxia and proliferation in high-grade glioma has been suspended. Sponsor: Weill Medical College of Cornell …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Leica Microsystems has initiated a post-market clinical follow-up study to collect data on the performance of the GLOW400 device when used a…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: fMRI Reveal Functional Preservation in Glioma Peritumoral Edema
A completed clinical trial reports that functional MRI demonstrates preserved function in glioma peritumoral edema.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
This completed clinical trial update reports location-molecular integrated outcomes from 450 cerebellar glioma microsurgical cases.